Pooyandegan Rah Saadat (aka Saadat), a company out of Tehran, Iran, has received the European CE Mark for its Aria portable patient monitor. The device features Masimo‘s rainbow SET Pulse CO-Oximetry and, according to a joint press release, it is the first portable monitor to do so. The portable device separates from the larger stationary unit to be used while transporting patients between different clinical wards.
Considering the last 30 years of the Washington/Tehran relationship, chances of seeing this device in the U.S. any time soon are rather slim. We also remember hearing something about embargoes and sanctions, but here’s an example of an American company doing business with Iran. We’re thinking it must be a medical exception. Reader comments explaining this are welcome below.
Aria is a cost-effective and lightweight (4.3″ display weighing < 2lbs) detachable patient monitor that integrates some of the most advanced noninvasive patient monitoring capabilities available today--including Masimo rainbow SET, CAS NIBP, Phasein multi-gas analyzer, and the Saadat Multi-Module (SMM) for ECG, respiration, IBP, temperature, and cardiac output--for use as both a bedside and transport vital signs monitor throughout the entire care path. As the first-and-only technology platform to noninvasively and continuously measure total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®) and Pleth Variability Index (PVI®), in addition to the 'gold-standard' Measure-Through Motion and Low Perfusion performance of Masimo SET® oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate (PR), Masimo rainbow®SET provides detailed physiological data that helps clinicians to more rapidly assess patients and detect adverse conditions much earlier.